PYGB and non-small cell lung carcinoma: The research also indicates that silencing PYGB can impede the advancement of NSCLC, proposing that PYGB could serve as a novel biomarker and a potential molecular therapeutic target for this malignancy (37).Due to these findings, it is speculated that PYGB might promote cancer similar to early studies (38).